By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Primagen Holding B.V. 

Meibergdreef 59
1105 BA
Amsterdam      The Netherlands
Phone: 31-20-566-8575 Fax: 31-20-566-9081


SEARCH JOBS


Industry
Biotechnology






Company News
Primagen Holding B.V. Validates Use Of Dry Filter Spot (DFS) HIV-1 Testing Service With Roche (RHHBY) COBAS AMPLICOR(R) HIV-1 Test 6/14/2006 12:27:45 PM
Primagen Holding B.V. Announces New Clinical Research Services For Angiogenesis And Free-Circulating DNA And RNA Cancer Biomarkers At American Society of Clinical Oncology 5/24/2006 10:37:41 AM
Primagen Holding B.V. Expands Into Cardiovascular Field With Technology License From The University of Texas M. D. Anderson Cancer Center 4/25/2006 10:32:50 AM
Primagen Holding B.V. Awarded U.S. Patent For Using Mitochondrial DNA Quantification As Biomarker 4/18/2006 12:37:19 PM
Primagen Holding B.V. Virus Discovery Group Chosen For EU-Funded GRACE Network Of Excellence 3/28/2006 12:12:24 PM
Primagen Holding B.V. Announces An Upgrade Of Their Dry Filter Spot (DFS) HIV-1 Testing Service For Resource Poor Settings With The Addition Of The Roche (RHHBY) COBAS AMPLICOR(R) HIV-1 Test v1.5 2/8/2006 12:57:56 PM
Primagen Holding B.V. Licenses Newly Discovered Coronavirus CoV-NL63 To bioMerieux, Inc. 2/1/2006 12:59:06 PM
Primagen Holding B.V. And Roche Molecular Systems, Inc. (RHHBF.PK) Initiate Discussions To Develop Dry Filter Spot Technology For HIV-1 Viral Load Testing In The Developing World10/19/2005 5:13:20 PM
Primagen Holding B.V. Receives "Notice Of Allowance" From The US Patent And Trademark Office10/19/2005 5:12:28 PM
Primagen Holding B.V. Announces Appointment Of President For Its US Subsidiary, Primagen Inc. 10/19/2005 5:12:00 PM
12
//-->